Please login to the form below

Not currently logged in
Email:
Password:

heart disease

This page shows the latest heart disease news and features for those working in and with pharma, biotech and healthcare.

The two ‘c’s’ of public health: confounding and causal inference*

The two ‘c’s’ of public health: confounding and causal inference*

And it is. Older people tend to have a greater prevalence of heart disease than younger people. ... 3. Age cannot be on the causal pathway between coronary heart disease and death.

Latest news

  • Segmentation, evolved Segmentation, evolved

    Elias Zerhouni, Sanofi’s Global R&D head, pointed to Sanofi’s thinking when he said: “Not all patients with heart disease are the same. ... The data demonstrates that a precision-medicine approach in the field of cardiovascular disease may further

  • Celixir cleared to start trial of stem cell therapy for heart failure Celixir cleared to start trial of stem cell therapy for heart failure

    Heart failure is still a major cause of death affecting millions of patients worldwide [and] current therapies do not reduce chronic myocardial scarring, diminish disease progression or prolong life, ”commented Prof ... The initial Heartcel trial

  • Abbott launches Bluetooth cardiac monitor Confirm RX in the US Abbott launches Bluetooth cardiac monitor Confirm RX in the US

    By offering a device that uses Bluetooth wireless technology from the patient’s smartphone, we can help physicians easily and remotely diagnosed potentially dangerous abnormal heart beats without requiring the patient ... Arrhythmia can develop when a

  • Forming a picture of health Forming a picture of health

    only likely to contribute to chronic disease in later life, but are already causing health problems among children. ... We have people who were afraid of dying of AIDS, who are now perhaps worrying about dying of diabetes or heart disease, the dying of

  • European Commission backs LEO Pharma’s Kyntheum European Commission backs LEO Pharma’s Kyntheum

    in the UK, a quarter of whom will have, or may develop, a moderate or severe form of the disease. ... People suffering from plaque psoriasis - the most common type of psoriasis affecting up to 97% of patients - are at an increased risk of developing

More from news
Approximately 6 fully matching, plus 303 partially matching documents found.

Latest Intelligence

  • Waking the sleeping giant Waking the sleeping giant

    While it is true that less than 50% of Africans enjoy access to modern healthcare facilities at present, and that Africa suffers from one-quarter of the world’s disease burden, ... In addition, SMS and voice messaging are being used for patient

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    Improving patient adherence… is one way of improving this efficiency as there is decreased spending on hospitalisations, re-admissions, disease progression and complications.”. ... 80% in just five disease areas - asthma, type 2 diabetes, coronary

  • A healthy challenge A healthy challenge

    All told, 50 million people in the EU are afflicted by conditions such as diabetes, congestive heart failure, chronic obstructive pulmonary disease and asthma, and in 2013 more than 1.2m

  • Deal Watch May 2016 Deal Watch May 2016

    Teva's drug SD 809 for the treatment of Huntington's disease was part of the acquisition of Auspex at a cost of $3.5bn. ... disease late last year, Bayer announced another gene editing pact this month with ERS Genomics.

  • Reaching new heights Reaching new heights

    Transformative medicine use. The overwhelming inertia in medicine use - where 97% of medicines used have been available for more than ten years - masks the contribution from transformative disease treatments, orphan drugs ... Disease treatments in 2020

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Energy drinks and heart disease

    Energy drinks and heart disease. Say Communications analyses the link between energy drinks and heart disease and how the issue has been covered in the media. ... me some quite unpleasant side effects – a racing heart and difficulty sleeping at night.

  • ECHO Medical Communications

    ECHO Medical Communications. ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.

  • Clark Health Communications unveils new positioning

    It is consistent with CHC’ s core belief that communication lies at the heart of fighting disease and keeping people well.

  • A man walks into a surgery: The role of storytelling in pharma marketing

    Our agency worked on the first omega-3 treatment indicated to prevent heart attacks, which originated from the finding that eskimos have a low incidence of heart disease, despite consuming high

  • Energy drinks and heart disease

    Energy drinks and heart disease. Say Communications analyses the link between energy drinks and heart disease and how the issue has been covered in the media. ... me some quite unpleasant side effects – a racing heart and difficulty sleeping at night.

More from PMHub
Approximately 2 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics